Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It’s Time to Move On!
Year: 2014
Type: article
Source: Diabetes Care
DOI: 10.2337/dc14-0565
Author: Saul Genuth
Institution: Case Western Reserve University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2097388209
